|
Symbol
|
IHTEFG | HZJEFG | Z09YGZ | RMA3QV | RMBRKV | ERORCH | ABMUTQ | PRZRCH | Z0ARNZ | CQWBKB | PWCRCH | LYXRCH | LYZRCH | LZMRCH | UJERWU | RMAT9V | RMBGJV | CZOBKB | RMBU5V | ACZESQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Name | Reverse Convertible | Reverse Convertible | Autocallable Reverse Convertible Defensive worst | Multi Vonti | Reverse Convertible | Worst of Callable Reverse Convertible | Multi Reverse Convertible | Worst of Callable Reverse Convertible | Autocallable Reverse Convertible Defensive worst | Reverse Convertible | Autocallable Reverse Convertible | Worst of Callable Reverse Convertible | Worst of Reverse Convertible | Worst of Reverse Convertible | GOAL | Reverse Convertible | Multi Vonti | Reverse Convertible | Multi Vonti | Reverse Convertible |
|
Basiswert
|
Compagnie Financière Richemont SA / Lonza Group N / Sonova Hldg. AG / Swiss RE AG / Swisscom N | Lonza Group N / Roche PS / Sika AG | Compagnie Financière Richemont SA / Lonza Group N / Schindler PS / Sika AG | Alcon / Lonza Group N / Novartis AG / Roche PS / Sandoz Group AG | Bucher Industries AG / Lonza Group N / Sika AG | BKW AG / Kühne & Nagel Intl. AG / Lonza Group N | Clariant AG / Comet Hldg. AG / Lonza Group N / OC Oerlikon N / Swatch Group I | Lonza Group N / Swiss Life Hldg. N / Swiss RE AG | Holcim/Amrize Basket / Lonza Group N / Sandoz Group AG | Lonza Group N / Novartis AG / Roche PS / Straumann Hldg. AG | Kühne & Nagel Intl. AG / Logitech International SA / Lonza Group N / Swiss RE AG / UBS Group AG | Logitech International SA / Lonza Group N / Partners Group Hldg. AG / Sika AG | Lonza Group N / SGS S.A. Ltd. / Swisscom N | Holcim AG / Swiss RE AG / Lonza Group N | Bachem Hldg. AG / Lonza Group N / Straumann Hldg. AG | Alcon / Lonza Group N / Partners Group Hldg. AG | Alcon / Lonza Group N / Novartis AG / Straumann Hldg. AG | Julius Baer Group / Kühne & Nagel Intl. AG / Lonza Group N / Partners Group Hldg. AG / UBS Group AG | Lonza Group N / Novartis AG / Straumann Hldg. AG / Ypsomed Hldg. AG | Compagnie Financière Richemont SA / Lonza Group N / Partners Group Hldg. AG / UBS Group AG |
|
Emittent
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fälligkeit
|
28.06.2029 | 02.11.2026 | 27.08.2027 | 09.11.2026 | 05.11.2026 | 06.11.2026 | 20.12.2029 | 24.02.2027 | 25.08.2026 | 13.03.2028 | 27.06.2029 | 07.10.2026 | 14.07.2027 | 31.07.2026 | 02.08.2027 | 12.08.2026 | 19.08.2027 | 15.08.2028 | 22.02.2027 | 25.08.2027 |
| Ratio | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
|
Ausübungs-Preis
|
176.28 | 182.298 | 179.883 | 56.14 | 197.80 | 100.685 | 6.7665 | 416.78 | 463.386 | 78.705 | 364.13 | 831.20 | 361.14 | 110.6625 | 75.3422 | 828.5956 | 51.80 | 570.50 | 292.70 | 718.90 |
|
Maximal- rendite p.a. |
- | - | 23.00% | 24.06% | 97.18% | 3.27% | 14.00% | 4.07% | 3.66% | 8.30% | 6.61% | 118.91% | 2.09% | -16.64% | 10.11% | 445.90% | 12.11% | 8.94% | 6.99% | 19.93% |
| Geld | 90.27 | 84.67 | - | 95.00 | 80.70 | 100.40 | 77.83 | 99.83 | - | 95.14 | 94.33 | 82.32 | 100.23 | 99.64 | 97.95 | 81.20 | 94.00 | 91.54 | 98.00 | 86.87 |
| Brief | - | - | - | 96.00 | 82.20 | 101.21 | 78.61 | 100.63 | - | 95.94 | 95.13 | 83.12 | 101.04 | 100.44 | 98.95 | 82.50 | 95.00 | 92.34 | 99.40 | 87.67 |